Acasti Pharma, Inc. engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil. The company was founded by Henri Harland on February 1, 2002 and is headquartered in Laval, Canada.
SHORT INTEREST
1.21M 09/30/19
P/E Current
-3.01
P/E Ratio (with extraordinary items)
-4.02
Average Recommendation: BUY
Average Target Price: 5.31
SHORT INTEREST
1.21M 09/30/19
P/E Current
-3.01
P/E Ratio (with extraordinary items)
-4.02
Average Recommendation: BUY
Average Target Price: 5.31
⭐⭐⭐ Sign Up for Free ⭐⭐⭐
1) Download our Mobile App >>
Android: dexwirenews.com/APP
Apple: dexwirenews.com/iOS
2) Join our Telegram >> t.me/DEXWireNews
3) Follow @DEXWireNews on Social Media
1) Download our Mobile App >>
Android: dexwirenews.com/APP
Apple: dexwirenews.com/iOS
2) Join our Telegram >> t.me/DEXWireNews
3) Follow @DEXWireNews on Social Media